Age of greatest susceptibility to childhood lead exposure: a new statistical approach

Richard W Hornung1, Bruce P Lanphear, Kim N Dietrich

  • 1Cincinnati Children's Environmental Health Center, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. richard.hornung@cchmc.org

Insights

Children aged 6 years with higher blood lead levels (BPb) show greater cognitive and behavioral deficits. This finding challenges the assumption that early childhood is the period of greatest lead susceptibility.

Area of Science:

  • Environmental Health
  • Pediatric Toxicology
  • Neurodevelopmental Science

Background:

  • Lead toxicity susceptibility is often assumed to be highest in early childhood.
  • Recent studies indicate a stronger association between blood lead concentrations (BPb) at 5-7 years and IQ.
  • This suggests a potential shift in the age of greatest susceptibility.

Purpose of the Study:

  • To determine the age of greatest susceptibility to lead exposure.
  • To employ an innovative statistical approach to overcome challenges with correlated serial BPb measurements.

Main Methods:

  • Analysis of two child cohorts (Rochester, NY; Cincinnati, OH) from infancy to 6 years.
  • Serial BPb measurements and IQ testing at 6 years of age.
  • Statistical modeling including the ratio of 6-year BPb to 2-year BPb to assess the impact of BPb profiles on IQ.

Main Results:

  • The ratio of BPb at 6 years to BPb at 2 years significantly impacted IQ (p < .001).
  • A 50% increase in 6-year BPb relative to 2-year BPb correlated with a 7.0-point decrease in IQ.
  • Higher 6-year BPb relative to 2-year BPb was also associated with a 3.35-fold increase in criminal arrest rates.

Conclusions:

  • Blood lead concentrations at 6 years of age are more strongly associated with cognitive and behavioral development than earlier childhood measurements.
  • This highlights later childhood as a critical period for lead exposure effects.
Abstract

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...